Tocqueville Asset Management L.P. Nektar Therapeutics Transaction History

Tocqueville Asset Management L.P.

$5.99 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $75,303 - $146,568	-23,755 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $89,024 - $293,608	-21,400 Reduced 47.39%	23,755 $128,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $33,031 - $56,150	-3,050 Reduced 6.33%	45,155 $610,000
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $125,472 - $180,864	9,600 Added 24.87%	48,205 $866,000
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $97,468 - $120,359	-5,900 Reduced 13.26%	38,605 $662,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $1.22 Million - $1.88 Million	-73,900 Reduced 62.41%	44,505 $890,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $20,422 - $24,643	-1,295 Reduced 1.08%	118,405 $2.01 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $234,748 - $350,778	-14,150 Reduced 10.57%	119,700 $1.99 Million
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $714,864 - $993,856	-42,400 Reduced 24.06%	133,850 $3.1 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $128,204 - $247,725	-8,860 Reduced 4.79%	176,250 $3.15 Million
Q4 2019 Jan 14, 2020	SELL	$15.87 - $23.12 $370,961 - $540,430	-23,375 Reduced 11.21%	185,110 $4 Million
Q3 2019 Oct 31, 2019	BUY	$16.91 - $36.27 $335,731 - $720,104	19,854 Added 10.53%	208,485 $3.8 Million
Q2 2019 Jul 31, 2019	SELL	$31.0 - $36.3 $1.42 Million - $1.66 Million	-45,650 Reduced 19.49%	188,631 $6.71 Million
Q1 2019 Apr 30, 2019	SELL	$31.58 - $46.35 $2.56 Million - $3.76 Million	-81,150 Reduced 25.73%	234,281 $7.87 Million
Q4 2018 Feb 08, 2019	BUY	$30.43 - $56.65 $3.3 Million - $6.14 Million	108,355 Added 52.33%	315,431 $10.4 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $2.5 Million - $3.68 Million	53,785 Added 35.09%	207,076 $12.6 Million
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $3.45 Million - $7.78 Million	74,495 Added 94.54%	153,291 $7.49 Million
Q1 2018 May 14, 2018	SELL	$57.4 - $108.44 $13.2 Million - $24.9 Million	-229,266 Reduced 74.42%	78,796 $8.37 Million
Q4 2017 Feb 13, 2018	BUY	$23.02 - $60.5 $1.29 Million - $3.38 Million	55,860 Added 22.15%	308,062 $18.4 Million
Q3 2017 Oct 30, 2017	BUY	$17.79 - $24.0 $4.49 Million - $6.05 Million	252,202	252,202 $6.05 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account